Why the Asia Pacific Pharmacogenetics Testing in...

ha aggiunto una foto Altre informazioni

2025-12-23 08:26:20 -

Why the Asia Pacific Pharmacogenetics Testing in Psychiatry/Depression Market Is Advancing Personalized Medicine

"Future of Executive Summary Asia Pacific Pharmacogenetics Testing in Psychiatry/Depression Market: Size and Share Dynamics CAGR Value Data Bridge Market Research analyzes that the Asia Pacific pharmacogenetics testing in psychiatry/depression market is expected to reach the value of USD 375.42 million by 2029, at a CAGR of 10.6% during the forecast period A DBMR team of experts and...

0 Commenti 0 condivisioni 28 Views